Scientists map path of Alzheimer's drug in healthy brains
NCT ID NCT06454721
Summary
This early-stage study aimed to understand how an experimental Alzheimer's drug, BIIB080, travels through the brain and spinal cord. Researchers gave a tiny, traceable dose of the drug to 5 healthy adults and used special brain scans to see where it went. The main goals were to map the drug's path and check for any immediate safety issues.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UC Davis
Sacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.